GlaxoSmithKline malaria vaccine phase 3 trial heralded

Nature Biotechnology volume 29, pages1060–1062(2011)Cite this article

Article metrics

Subjects

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

Rent or Buy

All prices are NET prices.

Author information

Affiliations

  1. London

    • Simon Franz

Authors

  1. Search for Simon Franz in:

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Franz, S. GlaxoSmithKline malaria vaccine phase 3 trial heralded. Nat Biotechnol 29, 1060–1062 (2011) doi:10.1038/nbt1211-1060b

Download citation